The current examine was based on the outcomes of relevant published research.

Acknowledgment

Figures 1 and a couple of have been created by Figdraw.

Qiandai Miao, Jianxia Zhang, and Yan Han contributed to writing and modifying of this evaluate. Shaoqing Li1, Weijia Lyu, Yan Han collected the information and created figures. All authors made a big contribution to the work reported, whether or not that is in the conception, examine design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave last approval of the model to be published; have agreed on the journal to which the article has been submitted; and comply with be accountable for all points of the work.

This work was funded by CACMS Innovation Fund (CI2021A02803).

Disclosure

The authors declared that they haven't any competing interests on this work.

1. Xian P, Xuedong Z, Xin X, et al. The oral microbiome financial institution of China. Int J Oral Sci. 2018;10(2). 2049-3169 (Electronic). doi:10.1038/s41368-018-0018-x

2. Peres MA, Macpherson LMD, Weyant RJ, et al. Oral diseases: a global public health problem. Lancet. 2019;394(10194):249-260. 1474-547X (Electronic). doi:10.1016/S0140-6736(19)31146-eight

3. Kourembanas S. Exosomes: autos of intercellular signaling, biomarkers, and vectors of cell therapy. Ann Rev Physiol. 2015;77(1):13-27. 1545-1585 (Electronic). doi:10.1146/annurev-physiol-021014-071641

4. Barzin M, Bagheri AM, Ohadi M, Abhaji AM, Salarpour S, Dehghannoudeh G. Application of plant-derived exosome-like nanoparticles in drug supply. Pharmaceut Develop Technol. 2023;28(5):383-402. 1097-9867 (Electronic). doi:10.1080/10837450.2023.2202242

5. Raimondo F, Morosi L, Chinello C, Magni F, Pitto M. Advances in membranous vesicle and exosome proteomics bettering biological understanding and biomarker discovery. PROTEOMICS. 2011;11(4):709-720. 1615-9861 (Electronic). doi:10.1002/pmic.201000422

6. Satheeshan G, Si AK, Rutta J, Venkatesh T. Exosome theranostics: comparative analysis of P body and exosome proteins and their mutations for clinical applications. Functional Amp. 2024;24(4). 1438-7948 (Electronic). doi:10.1007/s10142-024-01404-zero

7. Mathivanan S, Simpson RJ. ExoCarta: a compendium of exosomal proteins and RNA. PROTEOMICS. 2009;9(21):4997-5000. 1615-9861 (Electronic). doi:10.1002/pmic.200900351

8. Théry C. Exosomes: secreted vesicles and intercellular communications. F1000 Biol Reports. 2011;3. 1757-594X (Electronic). doi:10.3410/B3-15

9. van der Pol E, Böing A, Harrison P, Sturk A, Nieuwland R. Classification, capabilities, and clinical relevance of extracellular vesicles. Pharmacol Rev. 2012;64(3):676-705. 1521-0081 (Electronic).

10. Batrakova EV, Kim MS. Using exosomes, naturally-equipped nanocarriers, for drug supply. J Controlled Release. 2015;219:396-405. 1873-4995 (Electronic). doi:10.1016/j.jconrel.2015.07.030

11. Peng Q, Yang JY, Zhou GA-O. Emerging functions and clinical applications of exosomes in human oral diseases. Cell amp. 2020;10(1). 2045-3701 (Print). doi:10.1186/s13578-020-00424-zero

12. Lee YJ, Shin KJ, Jang HJ, et al. GPR143 controls ESCRT-dependent exosome biogenesis and promotes most cancers metastasis. Develop Cell. 2023;58(4):320-334.e8. 1878-1551 (Electronic). doi:10.1016/j.devcel.2023.01.006

13. Mashouri L, Yousefi H, Aref AR, Ahadi AM, Molaei F, Alahari SK. Exosomes: composition, biogenesis, and mechanisms in most cancers metastasis and drug resistance. Mol Cancer. 2019;18(1). 1476-4598 (Electronic). doi:10.1186/s12943-019-0991-5

14. Kamerkar S, LeBleu VS, Sugimoto H, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498-503. 1476-4687 (Electronic). doi:10.1038/nature22341

15. Mohammadi M, Zargartalebi H, Salahandish R, Aburashed R, Wey Yong K, Sanati-Nezhad A. Emerging applied sciences and business products in exosome-based mostly cancer diagnosis and prognosis. Biosensors Bioelectronics. 2021;183:113176. 1873-4235 (Electronic).

16. Zhang L, Yu D. Exosomes in most cancers improvement, metastasis, and immunity. Biochimica Et Biophysica Acta (BBA) - Reviews on Cancer. 2019;1871(2):455-468. 1879-2561 (Electronic). doi:10.1016/j.bbcan.2019.04.004

17. Zhao L, Wang H, Fu J, et al. Microfluidic-based exosome isolation and extremely sensitive aptamer exosome membrane protein detection for lung cancer prognosis. Biosensors Bioelectronics. 2022;214:114487. 1873-4235 (Electronic). doi:10.1016/j.bios.2022.114487

18. Shan S-K, Lin X, Li F, et al. Exosomes and Bone Disease. Current Pharmaceutical Design. 2020;25(42):4536-4549. 1873-4286 (Electronic). doi:10.2174/1381612825666191127114054

19. Sarhadi VK, Armengol G. Molecular biomarkers in cancer. Biomolecules. 2022;12(8):1021. doi:10.3390/biom12081021

20. Miron RJ, Estrin NE, Sculean A, Zhang Y. Understanding exosomes: part 2-Emerging leaders in regenerative drugs. Periodontology 2000. 2024;94(1):257-414. doi:10.1111/prd.12561

21. Wang J, Jing J, Zhou C, Fan Y. Emerging roles of exosomes in oral diseases development. Int J Oral Sci. 2024;16(1):4. doi:10.1038/s41368-023-00274-9

22. Johnstone R, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with launched vesicles (exosomes). J Biol Chemis. 1987;262(19):9412-9420. 0021-9258 (Print). doi:10.1016/S0021-9258(18)48095-7

23. Pan B, Johnstone RM, Johnstone RM. Fate of the transferrin receptor throughout maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell. 1983;33(3):967-978. (0092-8674 (Print)). doi:10.1016/0092-8674(83)90040-5

24. Johnstone RM. Revisiting the highway to the discovery of exosomes. Blood Cells Mol Dis. 2005;34(3):214-219. 1079-9796 (Print). doi:10.1016/j.bcmd.2005.03.002

25. Jeppesen DK, Fenix AM, Franklin JL, et al. Reassessment of Exosome Composition. Cell. 2019;177(2):428-445.e18. 1097-4172 (Electronic). doi:10.1016/j.cell.2019.02.029

26. Kimiz-Gebologlu I, Oncel SS. Exosomes: large-scale manufacturing, isolation, drug loading efficiency, and biodistribution and uptake. J Controlled Rel. 2022;347:533-543. 1873-4995 (Electronic). doi:10.1016/j.jconrel.2022.05.027

27. Coumans FAW, Brisson AR, Buzas EI, et al. Methodological pointers to review extracellular vesicles. Circulation Res. 2017;120(10):1632-1648. 1524-4571 (Electronic). doi:10.1161/CIRCRESAHA.117.309417

28. Jung MK, Mun JY. Sample preparation and imaging of exosomes by transmission electron microscopy. J Visualized Experiments. 2018; (131):56482. (1940-087X (Electronic)). doi:10.3791/56482

29. Deng Z, Wang J, Xiao Y, et al. Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-β-induced neurotoxicity. Theranostics. 2021;11(9):4351-4362. 1838-7640 (Electronic). doi:10.7150/thno.52436

30. Menon R, Dixon CL, Sheller-Miller S, et al. Quantitative proteomics by SWATH-MS of maternal plasma exosomes determine pathways associated with term and preterm delivery. Endocrinology. 2019;160(3):639-650. 1945-7170 (Electronic). doi:10.1210/en.2018-00820

31. Shen L, Li Y, Li R, et al. Placenta-related serum exosomal miR-155 derived from patients with preeclampsia inhibits eNOS expression in human umbilical vein endothelial cells. Int J Mol Med. 2018. 1791-244X (Electronic). doi:10.3892/ijmm.2018.3367

32. He L, Zhu W, Chen Q, et al. Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis. Theranostics. 2019;9(26):8206-8220. 1838-7640 (Electronic). doi:10.7150/thno.37455

33. Zhu J, Liu B, Wang Z, et al. Exosomes from nicotine-stimulated macrophages speed up atherosclerosis by means of miR-21-3p/PTEN-mediated VSMC migration and proliferation. Theranostics. 2019;9(23):6901-6919. 1838-7640 (Electronic). doi:10.7150/thno.37357

34. Nguyen CA-O, Sallam M, Islam MS, et al. Placental exosomes as biomarkers for maternal diseases: current advances in isolation, characterization, and detection. ACS Sensors. 2023;8(7):2493-2513. 2379-3694 (Electronic). doi:10.1021/acssensors.3c00689

35. Peterson MF, Otoc N, Sethi JK, Gupta A, Antes TJ. Integrated methods for exosome investigation. Methods. 2015;87:31-45. 1095-9130 (Electronic). doi:10.1016/j.ymeth.2015.04.015

36. Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in Exosome Isolation Techniques. Theranostics. 2017;7(3):789-804. 1838-7640 (Electronic). doi:10.7150/thno.18133

37. Zhang M, Hu S, Liu L, et al. Engineered exosomes from different sources for cancer-focused therapy. Signal Transduction Targeted Ther. 2023;8(1). 2059-3635 (Electronic). doi:10.1038/s41392-023-01382-y

38. Casadei L, Choudhury A, Sarchet P, et al. Cross-movement microfiltration for isolation, selective capture and release of liposarcoma extracellular vesicles. J Extracellular Vesicles. 2021;10(4). 2001-3078 (Print). doi:10.1002/jev2.12062

39. Li Y, Jacox LA, Little SH, Ko CC. Orthodontic tooth movement: the biology and clinical implications. The Kaohsiung J Med Sci. 2018;34(4):207-214. doi:10.1016/j.kjms.2018.01.007

40. Ni Z, Zhou S, Li S, et al. Exosomes: roles and therapeutic potential in osteoarthritis. Bone Res. 2020;8:25. doi:10.1038/s41413-020-0100-9

41. Miron RJ, Estrin NE, Sculean A, Zhang Y. Understanding exosomes: part 3-therapeutic + diagnostic potential in dentistry. Periodontology 2000. 2024;94(1):415-482. doi:10.1111/prd.12557

42. Liu A, Yang G, Liu Y, Liu T. Research progress in membrane fusion-based hybrid exosomes for drug delivery systems. Front Bioeng Biotechnol. 2022;10:939441. doi:10.3389/fbioe.2022.939441

43. Sun W, Zhao C, Li Y, et al. Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activity. Cell Discov. 2016;2(1):16015. doi:10.1038/celldisc.2016.15

44. Chang HP, Tseng YC. Miniscrew implant purposes in contemporary orthodontics. The Kaohsiung J Med Sci. 2014;30(3):111-115. doi:10.1016/j.kjms.2013.11.002

45. Huynh N, VonMoss L, Smith D, et al. Characterization of regulatory extracellular vesicles from osteoclasts. J Dental Res. 2016;95(6):673-679. doi:10.1177/0022034516633189

46. Holliday LS, McHugh KP, Zuo J, Aguirre JI, Neubert JK, Rody WJ. Exosomes: novel regulators of bone remodelling and potential therapeutic agents for orthodontics. Orthodontics Craniofacial Res. 2017;20 Suppl 1(Suppl 1):95-99. doi:10.1111/ocr.12165

47. Deng L, Wang Y, Peng Y, et al. Osteoblast-derived microvesicles: a novel mechanism for communication between osteoblasts and osteoclasts. Bone. 2015;79:37-42. doi:10.1016/j.bone.2015.05.022

48. Holliday LS, Faria LP, Rody WJ. Actin and actin-related proteins in extracellular vesicles shed by osteoclasts. Int J mol Sci. 2019;21(1):158. doi:10.3390/ijms21010158

49. Wang W, Qiao SC, Wu XB, et al. Circ_0008542 in osteoblast exosomes promotes osteoclast-induced bone resorption through m6A methylation. Cell Death Dis. 2021;12(7):628. doi:10.1038/s41419-021-03915-1

50. Peng B, Wang L, Han G, Cheng Y. Mesenchymal stem cell-derived exosomes: a potential cell-free therapy for orthodontic tooth stability administration. Stem Cell Res Ther. 2024;15(1):342. doi:10.1186/s13287-024-03962-3

51. Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Prim. 2017;3(1):1-4. (2056-676X (Electronic)).

52. Dragana R, Jelena M, Jovan M, Biljana N, Dejan M. Antibacterial efficiency of adjuvant photodynamic therapy and excessive-power diode laser in the treatment of young permanent teeth with chronic periapical periodontitis. A prospective clinical examine. Photodiagnosis Photodynamic Ther. 2023;41:103129. 1873-1597 (Electronic). doi:10.1016/j.pdpdt.2022.103129

53. Patil SA-O, Albogami SA-O, Hosmani JA-O, et al. Artificial intelligence within the analysis of oral diseases: functions and pitfalls. Diagnostics;12(5):1029. (2075-4418 (Print)). 10.3390/diagnostics12051029

54. Glowacki AJ, Yoshizawa S, Jhunjhunwala S, et al. Prevention of inflammation-mediated bone loss in murine and canine periodontal disease through recruitment of regulatory lymphocytes. Proceed Nat Acad Sci. 2013;110(46):18525-18530. 1091-6490 (Electronic). doi:10.1073/pnas.1302829110

55. Shen Z, Kuang S, Zhang Y, et al. Chitosan hydrogel included with dental pulp stem cell-derived exosomes alleviates periodontitis in mice by way of a macrophage-dependent mechanism. Bioactive Materials. 2020;5(4):1113-1126. (2452-199X (Electronic)). doi:10.1016/j.bioactmat.2020.07.002

56. Song X, Xue Y, Fan S, Hao J, Deng R. Lipopolysaccharide-activated macrophages regulate the osteogenic differentiation of bone marrow mesenchymal stem cells by exosomes. PeerJ. 2022;10:e13442. (2167-8359 (Print)). doi:10.7717/peerj.13442

57. Zhao M, Dai W, Wang H, et al. Periodontal ligament fibroblasts regulate osteoblasts by exosome secretion induced by inflammatory stimuli. Arch Oral Biol. 2019;105:27-34. 1879-1506 (Electronic). doi:10.1016/j.archoralbio.2019.06.002

58. Wang Y, Zhang X, Wang J, et al. Inflammatory periodontal ligament stem cells drive M1 macrophage polarization through exosomal miR-143-3p-mediated regulation of PI3K/AKT/NF-κB Signaling. Stem Cells. 2023;41(2):184-199. 1549-4918 (Electronic). doi:10.1093/stmcls/sxac087

59. Pu X, Ma S, Gao Y, Xu T, Chang PA-O, Dong L. Mesenchymal stem cell-derived exosomes: biological perform and their therapeutic potential in radiation injury. Cells. 2020;10(1):42. (2073-4409 (Electronic)). 10.3390/cells10010042

60. Wei J, Song Y, Du Z, et al. Exosomes derived from human exfoliated deciduous teeth ameliorate adult bone loss in mice through selling osteogenesis. J Mol Histol. 2020;51(4):455-466. (1567-2387 (Electronic)). doi:10.1007/s10735-020-09896-3

61. Wu JA-O, Chen L, Wang R, et al. Exosomes secreted by stem cells from human exfoliated deciduous teeth promote alveolar bone defect repair by means of the regulation of angiogenesis and osteogenesis. ACS Biomaterials Sci Amp. 2019;5(7):3561-3571. 2373-9878 (Electronic). doi:10.1021/acsbiomaterials.9b00607

62. Nakao Y, Fukuda T, Zhang Q, et al. Exosomes from TNF-α-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone loss. Acta Biomaterialia. 2021;122:306-324. 1878-7568 (Electronic). doi:10.1016/j.actbio.2020.12.046

63. Yu T, Mi N, Song Y, Xie WA-O. Exosomes miR-92a-3p from human exfoliated deciduous teeth inhibits periodontitis progression via the KLF4/PI3K/AKT pathway. J Periodontal Res. 2024;59(4):771-782. (1600-0765 (Electronic)). doi:10.1111/jre.13262

64. Mai Z, Chen H, Ye Y, et al. Translational and clinical functions of dental stem cell-derived exosomes. Frontiers in Genetics. 2021. 12. 1664-8021 (Print). doi:10.3389/fgene.2021.750990

65. Qiao X, Tang J, Dou L, et al. Dental Pulp stem cell-derived exosomes regulate anti-inflammatory and osteogenesis in periodontal ligament stem cells and promote the restore of experimental periodontitis in rats. Int J Nanomed. 2023;Volume 18:4683-4703. 1178-2013 (Electronic). doi:10.2147/IJN.S420967

66. Lin H, Chen H, Zhao X, et al. Advances of exosomes in periodontitis treatment. J Transl Med. 2022;20(1):279. doi:10.1186/s12967-022-03487-4

67. Borse V, Konwar AN, Buragohain P. Oral cancer diagnosis and perspectives in India. Sensors International. 2020;1:100046. 2666-3511 (Electronic). doi:10.1016/j.sintl.2020.100046

68. Dinesh Y, Ramani P, Yuwanati M, Ramalingam K, Gheena S. MicroRNA Profiling in circulating exosomes in oral squamous cell carcinoma: a scientific review. Cureus. 2023;15(8). 2168-8184 (Print).

69. Luo R, Liu M, Yang Q, et al. Emerging diagnostic potential of tumor-derived exosomes. Journal of Cancer. 2021;12(16):5035-5045. 1837-9664 (Print). doi:10.7150/jca.59391

70. Amrollahi P, Rodrigues M, Lyon CJ, Goel A, Han H, Hu TY. Ultra-sensitive automated profiling of EpCAM expression on tumor-derived extracellular vesicles. Frontiers in Genetics. 2019;10. 1664-8021 (Print). doi:10.3389/fgene.2019.01273

71. Leal AC, Mizurini DM, Gomes T, et al. Tumor-derived exosomes induce the formation of neutrophil extracellular traps: implications for the establishment of cancer-associated thrombosis. Scientific Reports. 2017;7(1). 2045-2322 (Electronic). doi:10.1038/s41598-017-06893-7

72. Sasabe EA-O, Tomomura A, Liu H, Sento S, Kitamura N, Yamamoto T. Epidermal growth factor/epidermal development factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma via macropinocytosis. Cancer Science. 2022;113(2):609-621. 1349-7006 (Electronic). doi:10.1111/cas.15225

73. Razzo BM, Ludwig N, Hong C-S, et al. Tumor-derived exosomes promote carcinogenesis of murine oral squamous cell carcinoma. Carcinogenesis. 2020;41(5):625-633. 1460-2180 (Electronic). doi:10.1093/carcin/bgz124

74. Chen JH, ATH W, Bamodu OA, et al. Ovatodiolide suppresses oral most cancers malignancy by down-regulating exosomal Mir-21/STAT3/β-catenin cargo and preventing oncogenic transformation of regular gingival fibroblasts. Cancers. 2019;12(1):56. (2072-6694 (Print)). 10.3390/cancers12010056

75. He L, Ping F, Fan Z, et al. Salivary exosomal miR-24-3p serves as a possible detective biomarker for oral squamous cell carcinoma screening. Biomedicine & Pharmacotherapy. 2020;121:109553. 1950-6007 (Electronic). doi:10.1016/j.biopha.2019.109553

76. Yu ZA-O, Liu XC, Wu M, et al. Untouched isolation enables targeted functional evaluation of tumour-cell-derived extracellular vesicles from tumour tissues. J Extracellular Vesicles. 2022;11(4). 2001-3078 (Electronic). doi:10.1002/jev2.12214

77. Ren JG, Zhang W, Liu B, et al. Clinical significance and roles in angiogenesis of circulating microparticles in oral cancer. J Dental Res. 2016;95(8):860-867. 1544-0591 (Electronic). doi:10.1177/0022034516641037

78. Li SA-O, Han Y, Lu M, et al. Mesenchymal stem cell-exosome-mediated matrix metalloproteinase 1 participates in oral leukoplakia and carcinogenesis by inducing angiogenesis. Journal of Oral Pathology & Medicine. 2022;51(7):638-648. 1600-0714 (Electronic). doi:10.1111/jop.13321

79. Zhan C, Yang X, Yin XA-O, Hou JA-O. Exosomes and other extracellular vesicles in oral and salivary gland cancers. Oral Diseases. 2020;26(5):865-875. 1601-0825 (Electronic). doi:10.1111/odi.13172

80. Zhang Q, Xiao Q, Yin H, et al. Milk-exosome primarily based pH/light delicate drug system to enhance anticancer activity against oral squamous cell carcinoma. RSC Advances. 2020;10(47):28314-28323. 2046-2069 (Electronic). doi:10.1039/D0RA05630H

81. Deng W, Meng Y, Wang B, et al. In vitro experimental study on the formation of microRNA-34a loaded exosomes and their inhibitory effect in oral squamous cell carcinoma. Cell Cycle. 2022;21(16):1775-1783. 1551-4005 (Electronic). doi:10.1080/15384101.2022.2070832

82. You Y, Tian Z, Du Z, et al. M1-like tumor-associated macrophages cascade a mesenchymal/stem-like phenotype of oral squamous cell carcinoma through the IL6/Stat3/THBS1 feedback loop. J Experim &amp. 2022;41(1). 1756-9966 (Electronic). doi:10.1186/s13046-021-02222-z

83. Wang WZ, Cao X, Bian L, et al. Analysis of mRNA-miRNA interaction community reveals the function of CAFs-derived exosomes in the immune regulation of oral squamous cell carcinoma. BMC Cancer. 2023;23(1). 1471-2407 (Electronic). doi:10.1186/s12885-023-11028-5

84. Zhao C, Zhang G, Liu J, Zhang C, Yao Y, Liao W. Exosomal cargoes in OSCC: current findings and potential features. PeerJ. 2020;8:e10062. 2167-8359 (Print). doi:10.7717/peerj.10062

85. Tian Y, Li S, Song J, et al. A doxorubicin supply platform utilizing engineered natural membrane vesicle exosomes for focused tumor therapy. Biomaterials. 2014;35(7):2383-2390. (1878-5905 (Electronic)). doi:10.1016/j.biomaterials.2013.11.083

86. Abati SA-O, Bramati C, Bondi S, Lissoni AA-O, Trimarchi MA-O. Oral cancer and precancer: a narrative assessment on the relevance of early prognosis. Int J Environ Res Public Health. 2020;17(24):9160. (1660-4601 (Electronic)). 10.3390/ijerph17249160

87. Zlotogorski-Hurvitz A, Dayan D, Chaushu G, Salo T, Vered M. Morphological and molecular features of oral fluid-derived exosomes: oral most cancers patients versus wholesome people. J Cancer Res Clin Oncol. 2016;142(1):101-110. 1432-1335 (Electronic). doi:10.1007/s00432-015-2005-three

88. Patel A, Patel S, Patel P, Mandlik DA-O, Patel K, Tanavde VA-O. Salivary exosomal miRNA-1307-5p predicts disease aggressiveness and poor prognosis in oral squamous cell carcinoma patients. Int J mol Sci. 2022;23(18):10639. (1422-0067 (Electronic)). 10.3390/ijms231810639

89. Guo H, Jiang W, Huang S, Huang XA-O, Li C. Serum exosome-derived biomarkers for the early detection of oral squamous cell carcinoma. Molecular and Cellular Biochemistry. 2021;476(12):4435-4447. 1573-4919 (Electronic). doi:10.1007/s11010-021-04254-7

90. Zhu P, Ji W, Li D, et al. Current standing of hand-foot-and-mouth disease. J Biomed Sci. 2023;30(1):15. 1423-0127 (Electronic)

91. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and management of enterovirus 71. Lancet Infect Dis. 2010;10(11):778-790. 1474-4457 (Electronic). doi:10.1016/S1473-3099(10)70194-eight

92. Alsop J, Flewett TH, Foster JR. "Hand-foot-and-mouth disease" in Birmingham in 1959. BMJ. 1960;2(5214):1708-1711. 0007-1447 (Print). doi:10.1136/bmj.2.5214.1708

93. Zhang X, Zhang Y, Li HA-O, Liu LA-O. Hand-foot-and-mouth disease-related enterovirus and the event of multivalent HFMD vaccines. Int J mol Sci. 2022;24(1):169. (1422-0067 (Electronic)). 10.3390/ijms24010169

94. Ruan Z, Liang Y, Chen Z, et al. Enterovirus 71 non-structural protein 3A hijacks vacuolar protein sorting 25 to spice up exosome biogenesis to facilitate viral replication. Front Microbiol. 2022. 13. (R1664-302X (Print)). doi:10.3389/fmicb.2022.1024899

95. Wang YA-O, Zhang S, Song W, et al. Exosomes from EV71-contaminated oral epithelial cells can switch miR-30a to promote EV71 infection. Oral Diseases. 2020;26(4):778-788. (1601-0825 (Electronic)). doi:10.1111/odi.13283

96. Wu J, Gu J, Shen L, et al. Exosomal MicroRNA-155 Inhibits Enterovirus A71 Infection by Targeting PICALM. Int J Biol Sci. 2019;15(13):2925-2935. (1449-2288 (Electronic)). doi:10.7150/ijbs.36388

97. Zhang X, Zhang H, Gu J, et al. Engineered Extracellular Vesicles for Cancer Therapy. Advanced Materials. 2021;33(14). 1521-4095 (Electronic). doi:10.1002/adma.202005709

98. Yao YA-O, Jiang Y, Song J, et al. Exosomes as potential useful nanomaterials for tissue engineering. Adv Healthcare Mat. 2023;12(16). (2192-2659 (Electronic)). doi:10.1002/adhm.202201989

99. Kase Y, Uzawa K, Wagai S, et al. Engineered exosomes delivering particular tumor-suppressive RNAi attenuate oral most cancers progression. Scientific Reports. 2021;11(1). 2045-2322 (Electronic). doi:10.1038/s41598-021-85242-1

100. Kamerkar SA-O, Leng C, Burenkova O, et al. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 results in potent monotherapy antitumor activity. Science Advances. 2022;8(7). 2375-2548 (Electronic). doi:10.1126/sciadv.abj7002

101. Luo H, Chen D, Li R, et al. Genetically engineered CXCR4-modified exosomes for supply of miR-126 mimics to macrophages alleviate periodontitis. J Nanobiotech. 2023;21(1). 1477-3155 (Electronic). doi:10.1186/s12951-023-01863-w

102. Shou J, Li S, Shi W, et al. 3WJ RNA nanoparticles-aptamer functionalized exosomes from M2 macrophages goal BMSCs to promote the healing of bone fractures. Stem Cells Translational Medicine. 2023. (2157-6580 (Electronic)). doi:10.1093/stcltm/szad052

103. Singh BN, Raghubanshi AS, Koffas M, Gupta VK. Microbial engineering biotechnologies. Biotechnol Adv. 2019;37(6):107399. doi:10.1016/j.biotechadv.2019.05.005

104. Zhang D, Qin X, Wu T, Qiao Q, Song Q, Zhang Z. Extracellular vesicles primarily based self-grown gold nanopopcorn for combinatorial chemo-photothermal therapy. Biomaterials. 2019;197:220-228. doi:10.1016/j.biomaterials.2019.01.024

105. Kim MS, Haney MJ, Zhao Y, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in most cancers cells. Nanomedicine. 2016;12(3):655-664. doi:10.1016/j.nano.2015.10.012

106. Shtam TA, Kovalev RA, Varfolomeeva EY, Makarov EM, Kil YV, Filatov MV. Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Commun Signaling. 2013;11(1):88. doi:10.1186/1478-811x-11-88

107. Wang H, Wang J, Liu T, Leng Y, Yang W. Stem cell-derived exosomal MicroRNAs: potential therapies in diabetic kidney illness. Biomed Pharmacother. 2023;164:114961. doi:10.1016/j.biopha.2023.114961

108. Chew JRJ, Chuah SJ, Teo KYW, et al. Mesenchymal stem cell exosomes enhance periodontal ligament cell capabilities and promote periodontal regeneration. Acta Biomater. 2019;89:252-264. doi:10.1016/j.actbio.2019.03.021

109. Mohammed E, Khalil E, Sabry D. Effect of adipose-derived stem cells and their exo as adjunctive therapy to nonsurgical periodontal therapy: a histologic and histomorphometric study in rats. Biomolecules. 2018;8(4):167. doi:10.3390/biom8040167

110. Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primer. 2017;3(1):17038. doi:10.1038/nrdp.2017.38

111. Zhang S, Teo KYW, Chuah SJ, Lai RC, Lim SK, Toh WS. MSC exosomes alleviate temporomandibular joint osteoarthritis by attenuating inflammation and restoring matrix homeostasis. Biomaterials. 2019;200:35-47. doi:10.1016/j.biomaterials.2019.02.006

112. Hu S, Chen B, Zhou J, et al. Dental pulp stem cell-derived exosomes revitalize salivary gland epithelial cell function in NOD mice by way of the GPER-mediated cAMP/PKA/CREB signaling pathway. J Transl Med. 2023;21(1):361. doi:10.1186/s12967-023-04198-zero

113. Kim JM, Kim JH, Kim K, et al. Tonsil mesenchymal stem cells-derived extracellular vesicles stop submandibular gland dysfunction in ovariectomized rats. Aging. 2022;14(5):2194-2209. doi:10.18632/aging.203947

114. Xiao XY, Zhang NN, Long YZ, Huang GL. Repair mechanism of radiation-induced salivary gland injury by hypoxia-pretreated human urine-derived stem cell exosomes. Oral Dis.

If you have any questions relating to where and just how to use https://stemcellprocedurescanada.com/https://stemcellprocedurescanada.com/, you could call us at our own web site.